Sunday, March 9, 2025
40.7 F
New York

Not just available, but also useful: we must keep pushing to improve open access to research

Stephen Hawking’s PhD thesis became freely available online this week, and promptly crashed a server following massive public interest.

It’s a clear example of the public appetite for open access scientific information, and of the potential reach when articles are available.

But most of the world’s academic literature is still only legally available behind a paywall.

It’s time we brought the idea of open access publication truly to fruition: not just so more people can read research, but also to improve the application of academic work to address issues such as health inequity and poverty.

A brief history of open access

The example of Hawking’s thesis backs up what we know already from the numbers: work that is freely available is at least two to three times more likely to be read than closed access articles, and is 47% more likely to be cited in Wikipedia.

Defined simply, “open access” publications refer to work that is freely available, licensed in way that allows broad use and reuse, and which is permanently archived in a public repository or open publishing platform.

This week marks the tenth anniversary of Open Access Week, and 15 years since the Budapest Open Access initiative (one of the first definitions of open access) was launched.

In the past 15 years open access has morphed somewhat. It started as a fairly niche proposal, with small numbers of open access publishers in operation and ad hoc networks of repositories. Now it’s a truly global movement. Thousands of open access articles are freely available either through publishing in open access journals, or via the many open institutional repositories globally.

There were 32.4 million accesses of content from Australian academic research repositories in 2014. But compared with the pace of change in the online newspaper or music industry, the adoption of open access to academic research is slow. Why? A few factors come into play.

Commercial agendas

One fundamental problem is that universities pay vast sums of money to support academic publishing through subscriptions. Most of this goes into the bank accounts of a small number of commercial publishers who have a powerful interest in not supporting wholesale change in business models.

This handful of publishers has been systematically buying up smaller publishers and journals, creating an oligopoly. They have now moved into ways of collecting revenues for open access via article processing charges (APCs) – payment for publication once a research paper has passed peer review.

APCs are levied by many, but not all, open access publishers (including not-for-profit ones). However, the highest APCs are seen at commercial publishers especially in their journals that are not fully open access – so-called hybrid journals, where costs can be up to US$5,000 per article.

Different definitions

Different descriptors of open access can be confusing.

Research made open in a journal is referred to as “gold”, and in an institutional repository it is “green”. Work made open illegally has been called “black”. But open access is also often used as a synonym for just free access of a static version of a paper PDF, with no right to reuse.

True open access takes the form of a fully digitally interoperable article, electronically marked with rich metadata that indicates who wrote it, and with a licence that allows use and reuse. Such papers can be used in teaching, included seamlessly in other academic work, and much more – all with clear attribution and credit to the original author.

These ideas have been consolidated into the “F.A.I.R.” principles to describe research that is findable, accessible, interoperable and reusable. A statement laying out these principles for Australian research was developed last year.

Leadership matters

The importance of strong leadership in pushing the case for open access is evident in the Netherlands. Dutch science minister Sander Dekker has taken on open access as a cause, which has resulted in a national plan for open science.

In Australia, open access policies are predominantly repository-based at the two big funders: the Australian Research Council and the National Health and Medical Research Council.

An overall national position would be immensely valuable. Positive first steps were made towards this when the Productivity Commission made a recommendation for national and states open access policies in the 2016 Inquiry into Intellectual Policy Arrangements. In August 2017 the federal government accepted this recommendation.

A vision and a pathway

Even if all the above issues were dealt with, open access will continue to advance piecemeal, unless we have a long-term clarification of what we’re aiming for and how to get there.

It’s important to note that increasing open access is not the end goal in itself. We need open access in order to fulfil other urgent priorities such as maximising collaboration, improving global health, and reducing poverty, and this is the theme of this year’s open access week.

It’s worth noting here that caution may be needed around open access to sensitive data, for example relating to patients or threatened species, or some commercial work.

An effective open access scholarly ecosystem requires a collaborative, long-term commitment to policies and infrastructure by key players. Examples of how this can take place were detailed this week by a publisher and COAR, the global repository association.

In 2017 it’s high time to look beyond narrow definitions of open access. Let’s focus on infrastructure planning and building for the next decade, where research outputs are available not just for reading, but also for effective application.

Hot this week

Latest Pharma & Biotech News: Breakthroughs in Treatments and Emerging Therapies

The pharmaceutical and biotechnology industries are at the forefront of scientific progress, continually advancing treatments and therapies to address an array of health conditions. With groundbreaking innovations and regulatory approvals shaping the market, keeping up with pharma news and biotech news is crucial for healthcare professionals, researchers, and investors alike. The latest developments in drug discovery, gene therapies, personalized medicine, and cutting-edge biopharmaceuticals are transforming the landscape of modern medicine. Understanding the current state of the pharma industry as operating businesses news analysis reveals the dynamic interplay between innovation, market forces, and patient care. This article explores the most recent breakthroughs in treatments, major pharmaceutical sector news, and the impact of emerging therapies on global healthcare.

A New Drug Stronger Than Fentanyl: Potential Risks, Benefits, and Medical Implications

In recent years, the opioid crisis has reached unprecedented levels, with fentanyl emerging as one of the deadliest drugs contributing to overdose-related fatalities. Now, a new drug stronger than fentanyl has entered the conversation, raising concerns among healthcare professionals, policymakers, and law enforcement agencies. As scientists and pharmaceutical companies continue to develop novel opioids for medical use, the potential risks and benefits of these powerful substances must be thoroughly examined. Understanding the implications of these new compounds is essential for balancing pain management needs with the ongoing fight against opioid misuse and addiction. Opioid analgesics have long been used to treat severe pain, particularly in cases of terminal illness, post-surgical recovery, and chronic pain conditions. However, the emergence of synthetic opioids that surpass the potency of fentanyl presents new challenges in both medicine and public health. These novel substances, which are sometimes referred to as "nieuwe drugs" in international discussions, demand careful scrutiny. Their introduction into clinical practice or illicit markets could have profound effects on overdose rates, addiction treatment approaches, and regulatory policies. This article explores the medical applications, risks, and ethical considerations associated with a new drug stronger than fentanyl, offering a comprehensive analysis for healthcare professionals and policymakers.

Breakthroughs in Depression Treatment: Exploring the Latest New Depression Medication Options

Depression remains one of the most pressing mental health challenges worldwide, affecting millions of individuals and profoundly impacting their quality of life. Over the years, significant strides have been made in understanding the neurobiological mechanisms underlying depression, leading to the development of innovative pharmacological treatments. The emergence of new depression medication has transformed treatment options, offering hope to individuals who have not responded well to traditional antidepressants. As researchers continue to explore novel mechanisms and refine therapeutic approaches, new drugs for depression are poised to revolutionize mental health care. This article delves into the latest advancements in depression treatment, examining how new depression meds are reshaping the landscape of pharmacological therapy and highlighting promising breakthroughs in drug development.

Breakthroughs in Cancer Treatment: Exploring the Potential of a New Cancer Medication

Cancer remains one of the most formidable challenges in modern medicine, affecting millions of lives globally. Despite advances in early detection, treatment, and supportive care, many forms of cancer remain resistant to conventional therapies, necessitating continuous research into novel approaches. The emergence of a new cancer medication can dramatically alter the treatment landscape, offering fresh hope to patients who have exhausted existing options. In recent years, innovative cancer drugs have targeted tumor biology with greater precision, leveraging mechanisms such as immunotherapy, targeted therapy, and personalized medicine. As researchers push the boundaries of medical science, the development of a new cancer drug has the potential to redefine treatment protocols, improve survival rates, and enhance the quality of life for patients battling this disease. The rapid evolution of oncology treatments underscores the importance of understanding how new cancer drugs work, their mechanisms of action, and their impact on patient outcomes. This article explores the latest breakthroughs in cancer treatment, delves into the science behind emerging medications, and assesses their potential in reshaping the future of cancer care. By examining the clinical research, real-world applications, and regulatory considerations, we provide a comprehensive analysis of how these advancements can influence both current and future cancer therapies.

Best Leukemia Meds: Understanding Treatment Options and Their Effectiveness

Leukemia is a complex and multifaceted malignancy that affects blood-forming tissues, primarily the bone marrow and lymphatic system. It encompasses a variety of subtypes, each with distinct pathological mechanisms and treatment approaches. Over the years, advancements in pharmacology have significantly improved survival rates and quality of life for leukemia patients. The development of targeted leukemia drugs and innovative treatment strategies has revolutionized the management of the disease. This article explores the best leukemia meds available today, analyzing their effectiveness, mechanisms of action, and potential side effects to provide a comprehensive resource for patients, caregivers, and healthcare professionals.

Topics

Latest Pharma & Biotech News: Breakthroughs in Treatments and Emerging Therapies

The pharmaceutical and biotechnology industries are at the forefront of scientific progress, continually advancing treatments and therapies to address an array of health conditions. With groundbreaking innovations and regulatory approvals shaping the market, keeping up with pharma news and biotech news is crucial for healthcare professionals, researchers, and investors alike. The latest developments in drug discovery, gene therapies, personalized medicine, and cutting-edge biopharmaceuticals are transforming the landscape of modern medicine. Understanding the current state of the pharma industry as operating businesses news analysis reveals the dynamic interplay between innovation, market forces, and patient care. This article explores the most recent breakthroughs in treatments, major pharmaceutical sector news, and the impact of emerging therapies on global healthcare.

A New Drug Stronger Than Fentanyl: Potential Risks, Benefits, and Medical Implications

In recent years, the opioid crisis has reached unprecedented levels, with fentanyl emerging as one of the deadliest drugs contributing to overdose-related fatalities. Now, a new drug stronger than fentanyl has entered the conversation, raising concerns among healthcare professionals, policymakers, and law enforcement agencies. As scientists and pharmaceutical companies continue to develop novel opioids for medical use, the potential risks and benefits of these powerful substances must be thoroughly examined. Understanding the implications of these new compounds is essential for balancing pain management needs with the ongoing fight against opioid misuse and addiction. Opioid analgesics have long been used to treat severe pain, particularly in cases of terminal illness, post-surgical recovery, and chronic pain conditions. However, the emergence of synthetic opioids that surpass the potency of fentanyl presents new challenges in both medicine and public health. These novel substances, which are sometimes referred to as "nieuwe drugs" in international discussions, demand careful scrutiny. Their introduction into clinical practice or illicit markets could have profound effects on overdose rates, addiction treatment approaches, and regulatory policies. This article explores the medical applications, risks, and ethical considerations associated with a new drug stronger than fentanyl, offering a comprehensive analysis for healthcare professionals and policymakers.

Breakthroughs in Depression Treatment: Exploring the Latest New Depression Medication Options

Depression remains one of the most pressing mental health challenges worldwide, affecting millions of individuals and profoundly impacting their quality of life. Over the years, significant strides have been made in understanding the neurobiological mechanisms underlying depression, leading to the development of innovative pharmacological treatments. The emergence of new depression medication has transformed treatment options, offering hope to individuals who have not responded well to traditional antidepressants. As researchers continue to explore novel mechanisms and refine therapeutic approaches, new drugs for depression are poised to revolutionize mental health care. This article delves into the latest advancements in depression treatment, examining how new depression meds are reshaping the landscape of pharmacological therapy and highlighting promising breakthroughs in drug development.

Breakthroughs in Cancer Treatment: Exploring the Potential of a New Cancer Medication

Cancer remains one of the most formidable challenges in modern medicine, affecting millions of lives globally. Despite advances in early detection, treatment, and supportive care, many forms of cancer remain resistant to conventional therapies, necessitating continuous research into novel approaches. The emergence of a new cancer medication can dramatically alter the treatment landscape, offering fresh hope to patients who have exhausted existing options. In recent years, innovative cancer drugs have targeted tumor biology with greater precision, leveraging mechanisms such as immunotherapy, targeted therapy, and personalized medicine. As researchers push the boundaries of medical science, the development of a new cancer drug has the potential to redefine treatment protocols, improve survival rates, and enhance the quality of life for patients battling this disease. The rapid evolution of oncology treatments underscores the importance of understanding how new cancer drugs work, their mechanisms of action, and their impact on patient outcomes. This article explores the latest breakthroughs in cancer treatment, delves into the science behind emerging medications, and assesses their potential in reshaping the future of cancer care. By examining the clinical research, real-world applications, and regulatory considerations, we provide a comprehensive analysis of how these advancements can influence both current and future cancer therapies.

Best Leukemia Meds: Understanding Treatment Options and Their Effectiveness

Leukemia is a complex and multifaceted malignancy that affects blood-forming tissues, primarily the bone marrow and lymphatic system. It encompasses a variety of subtypes, each with distinct pathological mechanisms and treatment approaches. Over the years, advancements in pharmacology have significantly improved survival rates and quality of life for leukemia patients. The development of targeted leukemia drugs and innovative treatment strategies has revolutionized the management of the disease. This article explores the best leukemia meds available today, analyzing their effectiveness, mechanisms of action, and potential side effects to provide a comprehensive resource for patients, caregivers, and healthcare professionals.

Latest Cancer Treatment Breakthroughs: Advancements in Pharmacological Therapies for Better Outcomes

Cancer remains one of the most pressing health challenges globally, with millions of lives affected each year. However, the landscape of cancer treatment is continuously evolving, with groundbreaking pharmacological advancements offering new hope. The latest cancer treatment options focus on precision medicine, immunotherapy, and targeted therapies that enhance patient survival and quality of life. With recent cancer treatment breakthroughs, researchers and clinicians are increasingly optimistic about improving patient outcomes and moving closer to a cure. This article explores the newest cancer treatment advancements, including innovative drug therapies, novel treatment mechanisms, and emerging trends in oncological pharmacology.

Does Exercise Lower Cholesterol? The Science Behind Physical Activity and Heart Health

Cholesterol plays a crucial role in various physiological processes, but elevated levels, particularly of low-density lipoprotein (LDL) cholesterol, are a major risk factor for cardiovascular disease. The link between physical activity and cholesterol reduction has been extensively studied, raising the question: Does exercise lower cholesterol? Research suggests that engaging in regular physical activity can contribute significantly to improving lipid profiles, reducing cardiovascular risk, and promoting overall metabolic health. The mechanisms through which exercise impacts cholesterol levels are complex, involving enhanced lipid metabolism, increased high-density lipoprotein (HDL) production, and improved arterial function. In this article, we will examine the scientific evidence on whether exercise can lower cholesterol, explore the physiological processes involved, and discuss the best exercise strategies for optimizing cholesterol levels.

Can You Reverse Coronary Heart Disease? Understanding Risks, Treatments, and Lifestyle Interventions

Coronary heart disease (CHD) remains one of the leading causes of mortality worldwide, affecting millions of individuals each year. As the primary driver of heart attacks and other cardiovascular complications, CHD has garnered significant attention from medical professionals and researchers alike. A common question many people ask is: Can you reverse coronary heart disease? This inquiry stems from a growing interest in alternative and lifestyle-based approaches to cardiovascular health. While conventional medicine offers various treatments, emerging research suggests that lifestyle interventions, medical therapies, and dietary adjustments may play a role in reversing certain aspects of CHD. Understanding the mechanisms, risks, and available interventions can help individuals make informed decisions about their heart health.

Related Articles

Popular Categories

spot_imgspot_img